The structure and function of serum opacity factor: A unique streptococcal virulence determinant that targets high-density lipoproteins

Journal of Biomedicine and Biotechnology

Volumn 2010, Issue , 2010, Pages

  Courtney, Harry S ^a   Pownall, Henry J ^b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; HIGH DENSITY LIPOPROTEIN; SERUM OPACITY FACTOR; STREPTOCOCCUS VACCINE; UNCLASSIFIED DRUG; BACTERIAL VACCINE; OPACITY FACTOR; PEPTIDE HYDROLASE;

BACTERIAL VIRULENCE; CELL ADHESION; CELL INVASION; HUMAN; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SERUM; STREPTOCOCCUS; STREPTOCOCCUS DYSGALACTIAE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES; STREPTOCOCCUS SUIS; BIOASSAY; CHEMISTRY; GENETICS; IMMUNOLOGY; METABOLISM; PATHOGENICITY; VIRULENCE;

ANIMALIA;

BACTERIAL VACCINES; BIOLOGICAL ASSAY; HUMANS; LIPOPROTEINS, HDL; PEPTIDE HYDROLASES; STREPTOCOCCUS; VIRULENCE;

EID: 77955369669     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2010/956071     Document Type: Review

References (94)

1. Ward H. K., Rudd G. V., Studies on haemolytic streptococci from human sources Australian Journal of Experimental Biology Medical Science 1938 16 181 192
2. Krumwiede E., Studies on a lipoproteinase of group A streptococci The Journal of Experimental Medicine 1954 100 6 629 639
3. Rowen R., The release of cholesterol esters from serum lipoproteins by extracts of certain group A streptococci Journal of Experimental Medicine 1961 114 807 823
4. Rowen R., Martin J., Enhancement of cholesterol esterification in serum by an extract of group-A streptococcus Biochimica et Biophysica Acta 1963 70 396 405
5. Saravani G. A., Martin D. R., Opacity factor from group A streptococci is an apoproteinase FEMS Microbiology Letters 1990 68 1-2 35 39
6. Courtney H. S., Zhang Y.-M., Frank M. W., Rock C. O., Serum opacity factor, a streptococcal virulence factor that binds to apolipoproteins A-I and A-II and disrupts high density lipoprotein structure Journal of Biological Chemistry 2006 281 9 5515 5521
7. Gillard B. K., Courtney H. S., Massey J. B., Pownall H. J., Serum opacity factor unmasks human plasma high-density lipoprotein instability via selective delipidation and apolipoprotein A-I desorption Biochemistry 2007 46 45 12968 12978
8. Cunningham M. W., Pathogenesis of group a streptococcal infections Clinical Microbiology Reviews 2000 13 3 470 511
9. Courtney H. S., Hasty D. L., Dale J. B., Molecular mechanisms of adhesion, colonization, and invasion of group A streptococci Annals of Medicine 2002 34 2 77 87
10. Courtney H. S., Hasty D. L., Li Y., Chiang H. C., Thacker J. L., Dale J. B., Serum opacity factor is a major fibronectin-binding protein and a virulence determinant of M type 2 Streptococcus pyogenes Molecular Microbiology 1999 32 1 89 98
11. Baums C. G., Kaim U., Fulde M., Ramachandran G., Goethe R., Valentin-Weigand P., Identification of a novel virulence determinant with serum opacification activity in Streptococcus suis Infection and Immunity 2006 74 11 6154 6162
12. Timmer A. M., Kristian S. A., Datta V., Jeng A., Gillen C. M., Walker M. J., Beall B., Nizet V., Serum opacity factor promotes group A streptococcal epithelial cell invasion and virulence Molecular Microbiology 2006 62 1 15 25 (Pubitemid 44386547)
13. Courtney H. S., Hasty D. L., Dale J. B., Serum opacity factor (SOF) of Streptococcus pyogenes evokes antibodies that opsonize homologous and heterologous sof-positive serotypes of group A streptococci Infection and Immunity 2003 71 9 5097 5103
14. Rehder C. D., Johnson D. R., Kaplan E. L., Comparison of methods for obtaining serum opacity factor from group A streptococci Journal of Clinical Microbiology 1995 33 11 2963 2967
15. Johnson D. R., Kaplan E. L., Microtechnique for serum opacity factor characterization of group A streptococci adaptable to the use of human sera Journal of Clinical Microbiology 1988 26 10 2025 2030
16. Rakonjac J. V., Robbins J. C., Fischetti V. A., DNA sequence of the serum opacity factor of group A streptococci: identification of a fibronectin-binding repeat domain Infection and Immunity 1995 63 2 622 631
17. Gillen C. M., Towers R. J., McMillan D. J., Delvecchio A., Sriprakash K. S., Currie B., Kreikemeyer B., Chhatwal G. S., Walker M. J., Immunological response mounted by Aboriginal Australians living in the Northern Territory of Australia against Streptococcus pyogenes serum opacity factor Microbiology 2002 148 1 169 178
18. Widdowson J. P., Maxted W. R., Grant D. L., The production of opacity in serum by group A streptococci and its relationship withthe presence of M antigen Journal of General Microbiology 1970 61 3 343 353
19. Johnson D. R., Kaplan E. L., A review of the correlation of T-agglutination patterns and M-protein typing and opacity factor production in the identification of group A streptococci Journal of Medical Microbiology 1993 38 5 311 315
20. Maxted W. R., Widdowson J. P., Fraser C. A., Ball L. C., Bassett D. C., The use of the serum opacity reaction in the typing of group-A streptococci Journal of Medical Microbiology 1973 6 1 83 90
21. Beall B., Gherardi G., Lovgren M., Facklam R. R., Forwick B. A., Tyrrell G. J., Emm and sof gene sequence variation in relation to serological typing of opacity-factor-positive group A streptococci Microbiology 2000 146 5 1195 1209
22. Kreikemeyer B., Talay S. R., Chhatwal G. S., Characterization of a novel fibronectin-binding surface protein in group A streptococci Molecular Microbiology 1995 17 1 137 145
23. Beres S. B., Richter E. W., Nagiec M. J., Sumby P., Porcella S. F., DeLeo F. R., Musser J. M., Molecular genetic anatomy of inter- and intraserotype variation in the human bacterial pathogen group A Streptococcus Proceedings of the National Academy of Sciences of the United States of America 2006 103 18 7059 7064
24. Jeng A., Sakota V., Li Z., Datta V., Beall B., Nizet V., Molecular genetic analysis of a group A Streptococcus operon encoding serum opacity factor and a novel fibronectin-binding protein, SfbX Journal of Bacteriology 2003 185 4 1208 1217
25. Green N. M., Zhang S., Porcella S. F., Nagiec M. J., Barbian K. D., Beres S. B., LeFebvre R. B., Musser J. M., Genome sequence of a serotype M28 strain of group A Streptococcus: potential new insights into puerperal sepsis and bacterial disease specificity Journal of Infectious Diseases 2005 192 5 760 770
26. McShan W. M., Ferretti J. J., Karasawa T., Suvorov A. N., Lin S., Qin B., Jia H., Kenton S., Najar F., Wu H., Scott J., Roe B. A., Savic D. J., Genome sequence of a nephritogenic and highly transformable M49 strain of Streptococcus pyogenes Journal of Bacteriology 2008 190 23 7773 7785
27. Katerov V., Lindgren P.-E., Totolian A. A., Schaln C., Streptococcal opacity factor: a family of bifunctional proteins with lipoproteinase and fibronectin-binding activities Current Microbiology 2000 40 3 149 156
28. Kreikemeyer B., Martin D. R., Chhatwal G. S., SfbII protein, a fibronectin binding surface protein of group A streptococci, is a serum opacity factor with high serotype-specific apolipoproteinase activity FEMS Microbiology Letters 1999 178 2 305 311
29. Lindgren P.-E., McGavin M. J., Signas C., Guss B., Gurusiddappa S., Hook M., Lindberg M., Two different genes coding for fibronectin-binding proteins from Streptococcus dysgalactiae. The complete nucleotide sequences and characterization of the binding domains European Journal of Biochemistry 1993 214 3 819 827
30. Takamatsu D., Osaki M., Tharavichitkul P., Takai S., Sekizaki T., Allelic variation and prevalence of serum opacity factor among the Streptococcus suis population Journal of Medical Microbiology 2008 57 4 488 494
31. Wertz J. E., McGregor K. F., Bessen D. E., Detecting key structural features within highly recombined genes PLoS Computational Biology 2007 3 1, article e14
32. Ton-That H., Marraffini L. A., Schneewind O., Protein sorting to the cell wall envelope of Gram-positive bacteria Biochimica et Biophysica Acta 2004 1694 13 269 278
33. Whittaker C. A., Hynes R. O., Distribution and evolution of von Willebrand/integrin A domains: widely dispersed domains with roles in cell adhesion and elsewhere Molecular Biology of the Cell 2002 13 10 3369 3387
34. Saravani G. A., Martin D. R., Characterisation of opacity factor from group-A streptococci Journal of Medical Microbiology 1990 33 1 55 60
35. Pownall H. J., Remodeling of human plasma lipoproteins by detergent perturbation Biochemistry 2005 44 28 9714 9722
36. Pownall H. J., Hosken B. D., Gillard B. K., Higgins C. L., Lin H. Y., Massey J. B., Speciation of human plasma high-density lipoprotein (HDL): HDL stability and apolipoprotein A-I partitioning Biochemistry 2007 46 25 7449 7459
37. Mehta R., Gantz D. L., Gursky O., Human plasma high-density lipoproteins are stabilized by kinetic factors Journal of Molecular Biology 2003 328 1 183 192
38. Han M., Gillard B. K., Courtney H. S., Ward K., Rosales C., Khant H., Ludtke S. J., Pownall H. J., Disruption of human plasma high-density lipoproteins by streptococcal serum opacity factor requires labile apolipoprotein A-I Biochemistry 2009 48 7 1481 1487
39. Rosales C., Gillard B. K., Courtney H. S., Blanco-Vaca F., Pownall H. J., Apolipoprotein modulation of streptococcal serum opacity factor activity against human plasma high-density lipoproteins Biochemistry 2009 48 33 8070 8076
40. Oehmcke S., Podbielski A., Kreikemeyer B., Function of the fibronectin-binding serum opacity factor of Streptococcus pyogenes in adherence to epithelial cells Infection and Immunity 2004 72 7 4302 4308
41. Gillen C. M., Courtney H. S., Schulze K., Rohde M., Wilson M. R., Timmer A. M., Guzman C. A., Nizet V., Chhatwal G. S., Walker M. J., Opacity factor activity and epithelial cell binding by the serum opacity factor protein of Streptococcus pyogenes are functionally discrete Journal of Biological Chemistry 2008 283 10 6359 6366
42. Talay S. R., Zock A., Rohde M., Molinari G., Oggioni M., Pozzi G., Guzman C. A., Chhatwal G. S., Co-operative binding of human fibronectin to Sfbl protein triggers streptococcal invasion into respiratory epithelial cells Cellular Microbiology 2000 2 6 521 535
43. Balbona K., Tran H., Godyna S., Ingham K. C., Strickland D. K., Argraves W. S., Fibulin binds to itself and to the carboxyl-terminal heparin-binding region of fibronectin Journal of Biological Chemistry 1992 267 28 20120 20125
44. Tomasini-Johansson B. R., Kaufman N. R., Ensenberger M. G., Ozeri V., Hanski E., Mosher D. F., A 49-residue peptide from adhesin F1 of Streptococcus pyogenes inhibits fibronectin matrix assembly Journal of Biological Chemistry 2001 276 26 23430 23439
45. Dombek P. E., Cue D., Sedgewick J., Lam H., Ruschkowski S., Finlay B. B., Cleary P. P., High-frequency intracellular invasion of epithelial cells by serotype M1 group A streptococci: M1 protein-mediated invasion and cytoskeletal rearrangements Molecular Microbiology 1999 31 3 859 870
46. Courtney H. S., Podbielski A., Lamont R. J., Group A Streptococcal invasion of host cells Bacterial Invasion of Host Cells 2004 Cambridge, UK Cambridge University Press 239 273
47. Kalia A., Bessen D. E., Natural selection and evolution of Streptococcal virulence genes involved in tissue-specific adaptations Journal of Bacteriology 2004 186 1 110 121
48. Bessen D. E., Sotir C. M., Readdy T. L., Hollingshead S. K., Genetic correlates of throat and skin isolates of group A streptococci Journal of Infectious Diseases 1996 173 4 896 900
49. Courtney H. S., Li Y., Twal W. O., Argraves W. S., Serum opacity factor is a streptococcal receptor for the extracellular matrix protein fibulin-1 Journal of Biological Chemistry 2009 284 19 12966 12971
50. Argraves W. S., Greene L. M., Cooley M. A., Gallagher W. M., Fibulins: physiological and disease perspectives EMBO Reports 2003 4 12 1127 1131
51. de Vega S., Iwamoto T., Yamada Y., Fibulins: multiple roles in matrix structures and tissue functions Cellular and Molecular Life Sciences 2009 66 11-12 1890 1902
52. Courtney H. S., Dale J. B., Hasty D. L., Mapping the fibrinogen-binding domain of serum opacity factor of group A streptococci Current Microbiology 2002 44 4 236 240
53. Courtney H. S., Hasty D. L., Dale J. B., Anti-phagocytic mechanisms of Streptococcus pyogenes: binding of fibrinogen to M-related protein Molecular Microbiology 2006 59 3 936 947
54. Courtney H. S., Nishimoto S. K., Dale J. B., Hasty D. L., Schmidt K. H., Relative contributions of Serum Opacity Factor (SOF) and Streptococcal fibronectin-binding protein x (Sfbx) to the virulence of group A streptococci Current Trends in Microbiology 2004 1 87 96
55. Parker T. S., Levine D. M., Chang J. C. C., Laxer J., Coffin C. C., Rubin A. L., Reconstituted high-density lipoprotein neutralizes gram-negative bacterial lipopolysaccharides in human whole blood Infection and Immunity 1995 63 1 253 258
56. Grunfeld C., Marshall M., Shigenaga J. K., Moser A. H., Tobias P., Feingold K. R., Lipoproteins inhibit macrophage activation by lipoteichoic acid Journal of Lipid Research 1999 40 2 245 252
57. Wu A., Hinds C. J., Thiemermann C., High-density lipoproteins in sepsis and septic shock: metabolism, actions, and therapeutic applications Shock 2004 21 3 210 221
58. Tang C., Liu Y., Kessler P. S., Vaughan A. M., Oram J. F., The macrophage cholesterol exporter ABCA1 functions as an anti-inflammatory receptor Journal of Biological Chemistry 2009 284 47 32336 32343
59. Molina-Portela M. P., Samanovic M., Raper J., Distinct roles of apolipoprotein components within the trypanosome lytic factor complex revealed in a novel transgenic mouse model Journal of Experimental Medicine 2008 205 8 1721 1728
60. Nizet V., Ohtake T., Lauth X., Trowbridge J., Rudisill J., Dorschner R. A., Pestonjamasp V., Piraino J., Huttner K., Gallo R. L., Innate antimicrobial peptide protects the skin from invasive bacterial infection Nature 2001 414 6862 454 457
61. Lau Y. E., Bowdish D. M. E., Cosseau C., Hancock R. E. W., Davidson D. J., Apoptosis of airway epithelial cells: human serum sensitive induction by the cathelicidin LL-37 American Journal of Respiratory Cell and Molecular Biology 2006 34 4 399 409
62. Vaisar T., Pennathur S., Green P. S., Gharib S. A., Hoofnagle A. N., Cheung M. C., Byun J., Vuletic S., Kassim S., Singh P., Chea H., Knopp R. H., Brunzell J., Geary R., Chait A., Zhao X.-Q., Elkon K., Marcovina S., Ridker P., Oram J. F., Heinecke J. W., Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL Journal of Clinical Investigation 2007 117 3 746 756
63. Rye K.-A., Barter P. J., Antiinflammatory actions of HDL: a new insight Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 11 1890 1891
64. Khovidhunkit W., Kim M.-S., Memon R. A., Shigenaga J. K., Moser A. H., Feingold K. R., Grunfeld C., Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host Journal of Lipid Research 2004 45 7 1169 1196
65. Urundhati A., Huang Y., Lupica J. A., Smith J. D., DiDonato J. A., Hazen S. L., Modification of high density lipoprotein by myeloperoxidase generates a pro-inflammatory particle Journal of Biological Chemistry 2009 284 45 30825 30835
66. Navab M., Anantharamaiah G. M., Reddy S. T., Van Lenten B. J., Ansell B. J., Fogelman A. M., Mechanisms of disease: proatherogenic HDLan evolving field Nature Clinical Practice Endocrinology and Metabolism 2006 2 9 504 511
67. Almengor A. C., Walters M. S., McIver K. S., Mga is sufficient to activate transcription in vitro of sof-sfbX and other Mga-regulated virulence genes in the group A streptococcus Journal of Bacteriology 2006 188 6 2038 2047
68. McLandsborough L. A., Cleary P. P., Insertional inactivation of virR in Streptococcus pyogenes M49 demonstrates that virR functions as a positive regulator of ScpA, FcRA, OF, and M protein FEMS Microbiology Letters 1995 128 1 45 51
69. Podbielski A., Flosdorff A., Weber-Heynemann J., The group A streptococcal virR49 gene controls expression of four structural vir regulon genes Infection and Immunity 1995 63 1 9 20
70. Caparon M. G., Scott J. R., Identification of a gene that regulates expression of M protein, the major virulence determinant of group A streptococci Proceedings of the National Academy of Sciences of the United States of America 1987 84 23 8677 8681
71. Kreikemeyer B., McIver K. S., Podbielski A., Virulence factor regulation and regulatory networks in Streptococcus pyogenes and their impact on pathogen-host interactions Trends in Microbiology 2003 11 5 224 232
72. McIver K. S., Heath A. S., Scott J. R., Regulation of virulence by environmental signals in group A streptococci: influence of osmolarity, temperature, gas exchange, and iron limitation on emm transcription Infection and Immunity 1995 63 11 4540 4542
73. Caparon M. G., Geist R. T., Perez-Casal J., Scott J. R., Environmental regulation of virulence in group A streptococci: transcription of the gene encoding M protein is stimulated by carbon dioxide Journal of Bacteriology 1992 174 17 5693 5701
74. Podbielski A., Peterson J. A., Cleary P., Surface protein-CAT reporter fusions demonstrate differential gene expression in the vir regulon of Streptococcus pyogenes Molecular Microbiology 1992 6 16 2253 2265
75. Reitmeyer J. C., Guthrie R. K., Steele J. H., The occurrence of nicotinamide adenine dinucleotide glycohydrolase and the serum opacity reaction in groups B, C, F and G streptococci Microbios 1989 58 236-237 183 187
76. Top F. H. Jr., Wannamaker L. W., The serum opacity reaction of Streptococcus pyogenes: frequency of production of streptococcal lipoproteinase by strains of different serological types and the relationship of M protein production Journal of Hygiene 1968 66 1 49 58
77. Johnson D. R., Kaplan E. L., VanGheem A., Facklam R. R., Beall B., Characterization of group A streptococci (Streptococcus pyogenes): correlation of M-protein and emm-gene type with T-protein agglutination pattern and serum opacity factor Journal of Medical Microbiology 2006 55 2 157 164
78. Luca-Harari B., Straut M., Cretoiu S., Surdeanu M., Ungureanu V., Van Der Linden M., Jasir A., Molecular characterization of invasive and non-invasive Streptococcus pyogenes isolates from Romania Journal of Medical Microbiology 2008 57 11 1354 1363
79. El Tayeb S. H. M., Nasr E. M. M., Serum opacity factor of Staphylococcus epidermidis Infection and Immunity 1977 15 1 335 336
80. Katerov V., Schalen C., Totolian A. A., Sequencing of genes within the vir regulon of Streptococcus pyogenes type M15an opacity factor positive serotype with low opacity factor expression Molecular and General Genetics 1994 245 1 78 85
81. Takamatsu D., Wongsawan K., Osaki M., Nishino H., Ishiji T., Tharavichitkul P., Khantawa B., Fongcom A., Takai S., Sekizaki T., Streptococcus suis in humans, Thailand Emerging Infectious Diseases 2008 14 1 181 183
82. Dale J. B., Penfound T., Chiang E. Y., Long V., Shulman S. T., Beall B., Multivalent group A streptococcal vaccine elicits bactericidal antibodies against variant M subtypes Clinical and Diagnostic Laboratory Immunology 2005 12 7 833 836
83. Schulze K., Medina E., Talay S. R., Towers R. J., Chhatwal G. S., Guzmn C. A., Characterization of the domain of fibronectin-binding protein I of Streptococcus pyogenes responsible for elicitation of a protective immune response Infection and Immunity 2001 69 1 622 625
84. Schulze K., Medina E., Guzmn C. A., Intranasal immunization with serum opacity factor (SOF) of Streptococcus pyogenes fails to protect mice against lethal mucosal challenge with a heterologous strain Vaccine 2006 24 9 1446 1450
85. McNeil S. A., Halperin S. A., Langley J. M., Smith B., Warren A., Sharratt G. P., Baxendale D. M., Reddish M. A., Hu M. C., Stroop S. D., Linden J., Fries L. F., Vink P. E., Dale J. B., Safety and immunogenicity of 26-valent group A streptococcus vaccine in healthy adult volunteers Clinical Infectious Diseases 2005 41 8 1114 1122
86. Yvan-Charvet L., Wang N., Tall A. R., Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses Arteriosclerosis, Thrombosis, and Vascular Biology 2010 30 2 139 143
87. Pownall H. J., Ehnholm C., The unique role of apolipoprotein A-I in HDL remodeling and metabolism Current Opinion in Lipidology 2006 17 3 209 213
88. Tchoua U., Rosales C., Gillard B. K., Streptococcal serum opacity factor enhances macrophage cholesterol efflux and plasma cholesterol esterification. submitted to The Journal of Biological Chemistry
89. Wang N., Silver D. L., Costet P., Tall A. R., Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1 Journal of Biological Chemistry 2000 275 42 33053 33058
90. Davidson W. S., Rosales C., Gillard B., Apolipoprotein A-I conformation in Streptococcal serum opacity factor-derived Neo HDL, a potent acceptor of macrophage cholesterol Proceedings of the Arteriosclerosis, Thrombosis and Vascular Biology Annual Conference 2010 San Francisco, Calif, USA. abstract P89
91. Rosales C., Tang D., Gillard B., Courtney H. S., Pownall H. J., Low dose Streptococcal serum opacity factor reduces plasma cholesterol in vivo Proceedings of the Arteriosclerosis, Thrombosis and Vascular Biology Annual Conference 2010 San Francisco, Calif, USA. abstract P357
92. Frankel A. E., Powell B. L., Duesbery N. S., Vande Woude G. F., Leppla S. H., Anthrax fusion protein therapy of cancer Current Protein and Peptide Science 2002 3 4 399 407
93. de Maio M., Therapeutic uses of botulinum toxin: from facial palsy to autonomic disorders Expert Opinion on Biological Therapy 2008 8 6 791 798
94. Sikri N., Bardia A., A history of streptokinase use in acute myocardial infarction Texas Heart Institute Journal 2007 34 3 318 327